Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Improving Diagnostic Safety Through STeatosis Identification, Risk Stratification, and Referral in the ED (STIRRED)

NCT06944353 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.

NCT NCT06944353
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06944353 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Improving Diagnostic Safety Through STeatosis Identification, Risk Stratification, and Referral in the ED (STIRRED)
Lead sponsor
Northwestern University
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
December 4, 2025
Completion date
July 31, 2028
Enrollment
4,704 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metabolic dysfunction-associated steatotic liver disease, non-alcoholic fatty liver disease, steatosis of liver